Intralesional anti-CD20 antibody for low-grade primary cutaneous B-cell lymphoma: Adverse reactions correlate with favorable clinical outcome

Holstein, Julia; Scheu, Alexander; Fend, Falko; Eberle, Franziska Carola; Yazdi, Amir Sadegh

dc.contributor.author	Holstein, Julia
dc.contributor.author	Scheu, Alexander
dc.contributor.author	Fend, Falko
dc.contributor.author	Eberle, Franziska Carola
dc.contributor.author	Yazdi, Amir Sadegh
dc.date.accessioned	2018-02-15T15:10:09Z
dc.date.available	2018-02-15T15:10:09Z
dc.date.issued	2017
dc.identifier.issn	1610-0387
dc.identifier.uri	http://hdl.handle.net/10900/80546
dc.language.iso	en	de_DE
dc.publisher	Wiley	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/ddg.13188	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Intralesional anti-CD20 antibody for low-grade primary cutaneous B-cell lymphoma: Adverse reactions correlate with favorable clinical outcome	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170815222223_01586
utue.publikation.seiten	319-323	de_DE
utue.personen.roh	Holstein, Julia
utue.personen.roh	Scheu, Alexander
utue.personen.roh	Fend, Falko
utue.personen.roh	Eberle, Franziska Carola
utue.personen.roh	Yazdi, Amir Sadegh
dcterms.isPartOf.ZSTitelID	Journal der Deutschen Dermatologischen Gesellschaft	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	15	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE